Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016

MMWR Morb Mortal Wkly Rep. 2016 May 27;65(20):520-1. doi: 10.15585/mmwr.mm6520a3.

Abstract

On January 31, 2016, the Santa Clara County Public Health Department (SCCPHD) was notified of a suspected case of meningococcal disease in a university undergraduate student. By February 2, two additional suspected cases had been reported in undergraduate students living on the same campus. The index patient (patient A) required intensive care, whereas patients B and C had milder illness; there were no deaths. All three patients were part of overlapping social networks and had attended the same events during the week before the onset of patient A's symptoms, but whether they had direct contact with one another could not be verified. Serogroup B Neisseria meningitidis was identified in cerebrospinal fluid and blood from patient A and in blood from patient B. Serogroup B has been responsible for all U.S. college outbreaks of meningococcal disease since 2011 (1). Laboratory results for patient C were inconclusive.

MeSH terms

  • Adolescent
  • California / epidemiology
  • Ciprofloxacin / therapeutic use
  • Contact Tracing
  • Disease Outbreaks / prevention & control*
  • Humans
  • Meningitis, Meningococcal / epidemiology*
  • Meningitis, Meningococcal / prevention & control*
  • Meningococcal Vaccines / administration & dosage
  • Neisseria meningitidis, Serogroup B / isolation & purification*
  • Social Support
  • Universities*
  • Young Adult

Substances

  • Meningococcal Vaccines
  • Ciprofloxacin